Literature DB >> 19654597

IBD: incidence of HSV and HPV with azathioprine.

Mario Cottone1, Sara Renna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19654597     DOI： 10.1038/nrgastro.2009.110

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Donny M Chen; Michelle L Pritchard; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05       Impact factor: 11.382

2.  Viral infections in renal allograft recipients treated with long-term immunosuppression.

Authors:  E S Spencer; H K Andersen
Journal:  Br Med J       Date:  1979-10-06

3.  Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.

Authors:  Gauree Gupta; Ebbing Lautenbach; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12       Impact factor: 11.382

4.  Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.

Authors:  B I Korelitz; S R Fuller; J I Warman; M D Goldberg
Journal:  Am J Gastroenterol       Date:  1999-02       Impact factor: 10.864

5.  Risk factors for opportunistic infections in patients with inflammatory bowel disease.

Authors:  Murat Toruner; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; Robert Orenstein; William J Sandborn; Jean-Frederic Colombel; Laurence J Egan
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

6.  Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.

Authors:  Jonathan I Warman; Burton I Korelitz; Mark R Fleisher; Ram Janardhanam
Journal:  J Clin Gastroenterol       Date:  2003-09       Impact factor: 3.062

7.  Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine.

Authors:  P Seksik; J Cosnes; H Sokol; I Nion-Larmurier; J-P Gendre; L Beaugerie
Journal:  Aliment Pharmacol Ther       Date:  2009-02-15       Impact factor: 8.171

Review 8.  Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.

Authors:  N Viget; G Vernier-Massouille; D Salmon-Ceron; Y Yazdanpanah; J-F Colombel
Journal:  Gut       Date:  2008-01-04       Impact factor: 23.059

9.  Higher incidence of abnormal Pap smears in women with inflammatory bowel disease.

Authors:  Sunanda Kane; Bahar Khatibi; Deepa Reddy
Journal:  Am J Gastroenterol       Date:  2007-10-17       Impact factor: 10.864
  9 in total
  4 in total

1.  HPV vaccination of immunocompromised hosts.

Authors:  S M Garland; J M L Brotherton; A B Moscicki; A M Kaufmann; M Stanley; N Bhatla; R Sankaranarayanan; S de Sanjosé; J M Palefsky
Journal:  Papillomavirus Res       Date:  2017-06-03

2.  Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides.

Authors:  Wolfgang Merkt; Ulrich Salzer; Jens Thiel; Ilona Jandova; Raoul Bergner; Ana C Venhoff; Nils Venhoff
Journal:  BMC Immunol       Date:  2021-04-12       Impact factor: 3.615

3.  Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection.

Authors:  João Moura; Sara Duarte; Ana Sardoeira; João Neves-Maia; Joana Damásio; Ricardo Taipa; Paula Carneiro; Esmeralda Neves; Ana Campar; Ernestina Santos
Journal:  Neurohospitalist       Date:  2022-04

Review 4.  Infections and Chronic Inflammatory Bowel Disease.

Authors:  Torsten Kucharzik; Christian Maaser
Journal:  Viszeralmedizin       Date:  2014-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.